CN Patent

CN102027007A — 长效的y2和/或y4受体激动剂

Assigned to Novo Nordisk AS · Expires 2011-04-20 · 15y expired

What this patent protects

本发明涉及一种PYY或PP肽衍生物或者其类似物，其衍生以一个或多个包括远端的四唑或羧酸基团的血清白蛋白结合侧链。此外，本发明涉及其组合物和治疗响应于Y受体调节的状况的方法。

USPTO Abstract

本发明涉及一种PYY或PP肽衍生物或者其类似物，其衍生以一个或多个包括远端的四唑或羧酸基团的血清白蛋白结合侧链。此外，本发明涉及其组合物和治疗响应于Y受体调节的状况的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102027007A
Jurisdiction
CN
Classification
—
Expires
2011-04-20
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.